116 related articles for article (PubMed ID: 6114963)
1. Use of somatostatin and somatostatin analogs in a patient with a glucagonoma.
Kahn CR; Bhathena SJ; Recant L; Rivier J
J Clin Endocrinol Metab; 1981 Sep; 53(3):543-9. PubMed ID: 6114963
[No Abstract] [Full Text] [Related]
2. Malignant somatostatinoma: clinical features and metabolic studies.
Axelrod L; Bush MA; Hirsch HJ; Loo SW
J Clin Endocrinol Metab; 1981 May; 52(5):886-96. PubMed ID: 6112232
[No Abstract] [Full Text] [Related]
3. Effects of somatostatin on insulin and glucagon in patients with insulinoma.
Fallucca F; Mirabella C; Tamburrano G; Gambardella S; Aufieri G; Barbetti F; Andreani D
J Endocrinol Invest; 1979; 2(3):257-60. PubMed ID: 231062
[TBL] [Abstract][Full Text] [Related]
4. [Behavior of plasma glucagon in experimental fasting and somatostatin test in islet cell tumors].
Drost H; Berger M; Berchtold P; Wiegelmann W; Zimmermann H; Gries FA
Med Welt; 1976 Jul; 27(28):1381-3. PubMed ID: 183080
[No Abstract] [Full Text] [Related]
5. Secretory response and immunochemical heterogeneity of glucagon in plasma and tumor extracts of a patient with glucagonoma.
Torre L; Vazquez JA; Blázquez E
Horm Res; 1986; 23(3):159-66. PubMed ID: 3005153
[TBL] [Abstract][Full Text] [Related]
6. [Pancreatic function tests].
Abe M; Ikeda Y; Yaginuma M; Shimizu N
Nihon Rinsho; 1969 Feb; 27(2):291-300. PubMed ID: 4306418
[No Abstract] [Full Text] [Related]
7. Letter: Somatostatin and insulinoma.
Christensen SE; Hansen AP; Lundbaek K; Orskov H; Seyer-Hansen K
Lancet; 1975 Jun; 1(7922):1426. PubMed ID: 49589
[No Abstract] [Full Text] [Related]
8. [Glucagonoma syndrome with a normal blood glucose curve].
González de Zárate Apiñariz P; Alonso Alonso J; Vázquez García JA; Hernández Calvo J; Burgos Bretones J; Aguirre Errasti C; Díaz Pérez JL
Med Clin (Barc); 1983 Oct; 81(9):396-8. PubMed ID: 6316044
[No Abstract] [Full Text] [Related]
9. Distribution of plasma glucagon immunoreactivity in a patient with suspected glucagonoma.
Valverde I; Lemon HM; Kessinger A; Unger RH
J Clin Endocrinol Metab; 1976 May; 42(5):804-8. PubMed ID: 178682
[TBL] [Abstract][Full Text] [Related]
10. Plasma glucagon in insulinoma.
Ohneda A; Matsuda K; Horigome K; Ishii S; Yanbe A; Maruhama Y
Acta Diabetol Lat; 1977; 14(5-6):219-28. PubMed ID: 207064
[TBL] [Abstract][Full Text] [Related]
11. Responses of patients with insulinomas to stimulators and inhibitors of insulin release that have been linked with cyclic adenosine monophosphate.
Lins PE; Efendić S
Diabetes; 1979 Mar; 28(3):190-5. PubMed ID: 221293
[No Abstract] [Full Text] [Related]
12. Glucose intolerance in a patient with insulinoma. Report of a case.
Christiansen J; Munkgaard S
Acta Chir Scand; 1974; 140(7):578-80. PubMed ID: 4376322
[No Abstract] [Full Text] [Related]
13. A malignant insulinoma transformed into a glucagonoma syndrome.
Ohneda A; Otsuki M; Fujiya H; Yaginuma N; Kokubo T; Ohtani H
Diabetes; 1979 Nov; 28(11):962-9. PubMed ID: 226443
[No Abstract] [Full Text] [Related]
14. Somatostatin analogue in treatment of coexisting glucagonoma and pancreatic pseudocyst: dissociation of responses.
Moattari AR; Cho K; Vinik AI
Surgery; 1990 Sep; 108(3):581-7. PubMed ID: 2168587
[TBL] [Abstract][Full Text] [Related]
15. [Glucagonoma and somatostatinoma].
Yoshida H; Shimizu N
Nihon Rinsho; 1982 Feb; 40(2):441-5. PubMed ID: 6283209
[No Abstract] [Full Text] [Related]
16. Effect of somatostatin in the Syrian hamster bearing a transplantable islet-cell tumor.
Luyckx AS; Lefebvre PJ
Horm Metab Res; 1978 Mar; 10(2):105-10. PubMed ID: 206496
[TBL] [Abstract][Full Text] [Related]
17. [Glucagonoma syndrome with normal blood glucagon ].
Quencez E; Zultak M; Blanc D; Gillet M; Laurent R
Ann Dermatol Venereol; 1987; 114(9):1103-8. PubMed ID: 2829690
[No Abstract] [Full Text] [Related]
18. The metabolic effects of chronic hyperglucagonaemia.
Nankervis A; Proietto J; Ng KW; Alford FP; Larkins R
Clin Endocrinol (Oxf); 1981 Oct; 15(4):325-33. PubMed ID: 6274544
[TBL] [Abstract][Full Text] [Related]
19. Treatment of inoperable glucagonoma with the long-acting somatostatin analogue SMS 201-995.
Boden G; Ryan IG; Eisenschmid BL; Shelmet JJ; Owen OE
N Engl J Med; 1986 Jun; 314(26):1686-9. PubMed ID: 2872592
[No Abstract] [Full Text] [Related]
20. Five cases of somatostatinoma: clinical heterogeneity and diagnostic usefulness of basal and tolbutamide-induced hypersomatostatinemia.
Pipeleers D; Couturier E; Gepts W; Reynders J; Somers G
J Clin Endocrinol Metab; 1983 Jun; 56(6):1236-42. PubMed ID: 6132927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
